Clinical Trial Update: Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Xenon-129 and inert fluorinated gas lung MRI in healthy volunteers and patients with pulmonary disease. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Cystic Fibrosis

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Cystic Fibrosis, Asthma | Phase 2 | Status: RECRUITING